Wagner D K, Harris T, Madans J H
Office of Analysis and Epidemiology, Centers for Disease Control and Prevention, Hyattsville, Maryland 20782.
Environ Res. 1994 Aug;66(2):160-72. doi: 10.1006/enrs.1994.1052.
A standard laboratory renal assessment, concentration of albumin in urine, has been suggested as a biomarker of renal damage, but little data exist on its ability to predict health outcomes in the general population. This 16-year follow-up study of a general population evaluated the utility of this assessment to predict subsequent serious health consequences. Four percent of men and 2% of women aged 45-74 years exhibited proteinuria in a cross-sectional screening of an ambulatory population, with the percentage increasing with age. The finding of proteinuria was predictive of serious health consequences, with adjusted relative risks for subsequent mortality of 1.71 for men and 1.84 for women and adjusted relative risks for renal disease incidence of 3.46 in men and 1.39 in women. Controlling for those factors which might be associated with proteinuria and even excluding early cases did not alter these findings. These data support that causal proteinuria should be considered as a marker for risk of poor health outcomes.
一项标准的实验室肾脏评估指标——尿白蛋白浓度,已被提议作为肾脏损伤的生物标志物,但关于其在普通人群中预测健康结局能力的数据却很少。这项针对普通人群的16年随访研究评估了该评估指标预测后续严重健康后果的效用。在对流动人群的横断面筛查中,45 - 74岁的男性中有4%、女性中有2%出现蛋白尿,且该比例随年龄增长而增加。蛋白尿的发现可预测严重的健康后果,男性后续死亡的调整相对风险为1.71,女性为1.84;男性肾病发病率的调整相对风险为3.46,女性为1.39。控制那些可能与蛋白尿相关的因素,甚至排除早期病例,这些发现都没有改变。这些数据支持应将因果性蛋白尿视为健康结局不佳风险的标志物。